Find a TenderPast planning noticePreliminary market engagement notice
Published 16 Jul 2025, 09:26 BST

Official UK procurement notice

EoECPH - Pharmaceutical Wholesale Services

Official notice

Authority: East Of England NHS Collaborative Hub c/o West Suffolk NHS Foundation Trust (Central government)

Framework agreementServicesAbove thresholdSME suitableVCSE suitable
Sectors: Health & Social Care (85) Delivery: UK
Planned pipeline value£12,000,000,000pipeline notice, not a live tender
Tender notice expected 24 Nov 2025from the planned procurement notice
Framework period 4 yrsends 30 Jun 2030 · up to 30 Jun 2030 with extensions · starts 1 Jul 2026

What is being bought

Published requirement description

The Commercial schedule is comprised of discounts offered and innovative pricing:

The market can be categorised into contracted lines, non-contract (agency lines) and non-contract lines eligible for discount, the focal point of the commercial element of this framework agreement.

Innovative offers will not be evaluated as part of the commercial offering but will be considered by local trusts when selecting the most appropriate bidder for their specific service and requirements.

The projected value of service delivery, inclusive of all medicines expenditure under this framework, is estimated at £15,000,000,000 (£15billion) over the four years contract period. The proposed figure accounts for growth in this service area. The proportion of spend considered influenceable has been calculated at approximately 1.2% of the total contract value.

Influenceable Spend:

  • Includes products defined by the wholesalers as ‘Qualifying Non-contract lines’. The products defined under this term will vary throughout the life of the framework agreement. Each participating wholesaler will negotiate existing and new medicine distribution contracts with participating manufacturers. EoECPH have no influence on which manufacturers and products are defined as ‘Qualifying Non-contract lines’.
  • Where wholesalers provide their ‘Qualifying Non-contract line’ product list EoECPH may be able to influence through the procurement of Pharmaceutical wholesale Services.
  • We estimate this to be on average 1.2% of the total annual spend through the framework. This figure is based on the current EoECPH framework which is in year 4 of its 4 year term.

Non Influenceable Spend:

  • EOECPH will not ask bidders to submit prices for the medicines purchased.
  • NHS Contract Medicines prices are set through frameworks managed by NHS England Medicines Procurement and Supply Chain team
  • EOECPH is unable to influence these prices.
  • Wholesalers distribute a large proportion of MPSC NHS contracted medicines. Therefore total spend through the wholesaler services framework reflects this spend value.
  • Non contract (Non-Qualifying Agency lines) - Pricing is agreed between the manufacturer and wholesaler.
  • EOECPH is unable to influence these prices.

Total Spend

  • This is the ‘headline’ figure.
  • Combined influenceable and Non Influenceable Spend (MPSC NHS contracted lines + Non-contract agency lines).
  • We estimate this total combined medicines spend could be up to £15bn over the 4 year term.

The above figures include the 7 regions nationwide. This figure may change if further information comes to the attention of EOECPH. High level Spend data has been sourced using Exend (RxInfo software) NHS Medicines spend data to obtain an indicative National picture. High level data provided by two of the four main suppliers on the current framework supports the proposed spend value.

CPV: Pharmacy services

How this framework works

From the published notice
Framework period
4 yrs from 1 Jul 2026

The lotProcurement structure

single lot · no lot value published
Lot #1PlannedRenewal 4 yrsSMEVCSE
Contract period: 1 Jul 2026 – 30 Jun 2030 (4 yrs) · up to 30 Jun 2030 with extensions
Delivery: UKEligibility: SME eligibleVCSE eligible
Extensions: Extension options published

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
What this means for your bid
  • “EoECPH - Pharmaceutical Wholesale Services” is a framework: the contest is a place on its panel, not a single contract.

Procedure terms & legal framework

From the official record
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Services
Notice status
Past planning notice
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
16 Jul 2025, 09:26 BST
Last source update
7 Oct 2025, 13:49 BST
Authority reference
C386060
FTS notice number
2025/S 000-062882
Latest notice
Preliminary market engagement notice (UK2)
Classification (CPV)
Pharmacy services
Delivery area
UK
Official registry OCID
ocds-h6vhtk-055ffd Find a Tender

How it was run

Official notice
Appointment period ends
—

Timeline

16 Jul 2025 → 1 Jul 2026 · 5 dates
  1. Planning notice published
    16 Jul 2025, 09:26 BST
  2. Latest notice published385 days ago
    7 Oct 2025, 13:49 BST
  3. Market engagement371 days ago
    21 Oct 2025, 23:59 BST

    EoECPH – Pharmaceutical Wholesale Services Preliminary Market Engagement Notice

    The East of England NHS Collaborative Procurement Hub (the Authority) is procuring a Framework Agreement for the provision of Pharmaceutical Wholesale Services. The aims and objectives of the Framework Agreement is to provide an appropriate route to market for Pharmaceutical Wholesale Services for participating NHS Trusts. This framework agreement is for the provision of pharmaceutical wholesale services to member organisations of the East of England Collaborative Procurement HUB (EoECPH), NHS Commercial Solutions (NHS CS), South East Pharmacy Procurement Service (SEPPs) and Peninsula Purchasing & Supply Alliance (PPSA). The framework agreement is available to any publicly funded entities (not already a full or pharmacy member of the above mentioned organisation(s)) who sign the framework customer access agreement.

    The purpose of the PME is to gauge interest and connect with providers within this market-place to better understand market interest, capability and capacity to deliver the requirements. This notice is for information only and the Contracting Authority reserves the right to not proceed to tender or at its absolute discretion to amend it at the time of issue of any further notice or notices or at any other time.

    As part of this pre-tender strategy, EOECPH would like to connect with providers of this type of service via a pre-market engagement exercise. We are therefore asking for assistance through completion of our questionnaire. The information provided will help us to form and shape the way the service specification is refreshed and updated for a framework that will last 4 years.

    Potential Scope and Service Requirements

    This framework agreement is for the provision of safe, legal, efficient and cost-effective pharmaceutical wholesale services comprising the delivery of medicines and other pharmaceutical products to Participating Authorities.

    The scope includes a requirement for the suppliers to work with Trusts, where reasonable and practicable, to meet the needs of the changing landscape such as seven day working or projects which integrate clinical pharmacy services and support risk avoidance and clinical governance agendas.

    Framework Details

    Procurement Procedure: Open

    Proposed Framework Length: 48 months

    The projected value of service delivery, inclusive of medicines expenditure under this framework, is estimated at £15,000,000,000 (£15billion) over the four years contract period. The proportion of spend considered influenceable has been calculated at approximately 1.2% of the total contract value.

    Our intention is to award all bidders who meet a specified technical /quality/Social Value threshold on an unranked basis. This is intended to ensure the framework agreement can be utilised as a contractual vehicle allowing participating authorities to select their preferred supplier based on their particular needs in accordance with the call-off procedure

    The main objectives of this procurement are:

    • Coverage of all key market players
    • Competitive prices delivering cost savings against some previous framework rates
    • Compliant route to market for Pharmaceutical Wholesale Services
    • Robust call-off procedure providing significant contract management

    The market can be categorised into contracted lines, non-contract (agency lines) and non-contract lines eligible for discount, the focal point of the commercial element of this framework agreement.

    This new framework agreement utilises the national service specification for pharmaceutical wholesale services and the national key performance indicators. The scope of the agreement remains fundamentally unchanged from the outgoing framework with a selection of refinements based on learnings over the previous framework period.

    Service Fundamentals

    Suppliers will work in partnership with the Purchasing Authority to ensure:

    • Patient safety
    • Best possible clinical outcomes
    • Patient satisfaction
    • Minimal additional costs to the Participating Authority as a publicly funded body

    The Purchasing Authority and Supplier will comply with the current Professional Standards. To the extent applicable, the Supplier and Purchasing Authority shall comply with all requirements of relevant regulatory bodies e.g. General Pharmaceutical Council, Medicines and Health Regulatory Agency, Care Quality Commission and Nursing and Midwifery Council.

    The Contracting Authority intends to use an eTendering system, Atamis, in any resulting procurement exercise.

    The questionnaire will run on:

    The Atamis portal:

    health-family.force.com/s/Welcome ↗

    How to access the Questionnaire on the portal:

    • Suppliers should register on the portal, if not already registered:
    • To Express an Interest in this market engagement, search and Select contract reference - C386060- Market Engagement – EoECPH – Pharmaceutical Wholesale Services
    • Please complete the questionnaire within the requirements section
    • Suppliers can contact the Atamis helpdesk at -

    support-health@atamis.co.uk or by calling 0800 9956035 for technical assistance when completing responses

    The closing time and date for the return of your responses are 12:00 Midday on 21 October 2025. Responses received after this date may be considered at EoECPH discretion. We would like to take this opportunity to thank you for your interest and participation.

  4. Tender notice expected337 days ago
    24 Nov 2025, 23:59 GMT
  5. Contract starts119 days ago
    1 Jul 2026, 00:00 BST

Notice history

2 events · 2 releases on Find a Tender · since 16 Jul 2025
  1. Pipeline notice published
    16 Jul 2025, 09:26 BST
    UK1
  2. Preliminary market engagement notice published
    7 Oct 2025, 13:49 BST
    UK2

Commercial outcome & contract awards

Pipeline notice
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Contracting authority & participating public bodies

East Of England NHS Collaborative Hub c/o West Suffolk NHS Foundation Trust

Contracting authorityPublic authority - central government GB-PPON: PXMB-9766-NLTH Victoria House, Camlife, Cambridge Road, Fulbourn, East of England, CB21 5XAContact email

Official documents & specifications (2)

Official links; attachments are not copied

Notices published for this procedure